Vaccinex, Inc. announced that it has entered into a securities purchase agreement to issue 159,683 shares of common stock at a combined price of $7.77 per share and accompanying warrants for the gross proceeds of $1,240,736.91 on March 27, 2024. Each Private Placement Warrant has an initial exercise price of $7.64 per share, is immediately exercisable, and expires March 28, 2029. The sale of the Private Placement Securities was not registered under the Securities Act, and the Private Placement Securities were issued and sold in a private placement pursuant to Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D as promulgated by the SEC under the Securities Act.

The transaction will include participation from returning investors FCMI Parent Co. and Vaccinex (Rochester), L.L.C.